Westpac Banking Corp
WBC
Woodside Energy Group Ltd
WDS
CommBank
CBA
ANZ Group Holdings Ltd
ANZ
National Australia Bank Ltd
NAB
Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.